Relationship between lentin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease

被引:13
|
作者
Atamer, A. [1 ]
Ecder, S. Alisir [2 ]
Akkus, Z. [3 ]
Kocyigit, Y. [4 ]
Atamer, Y. [5 ]
Ilhan, N. [6 ]
Ecder, T. [7 ]
机构
[1] Diyarbakir Training & Res Hosp, Dept Internal Med, Diyarbakir, Turkey
[2] Goztepe Training & Res Hosp, Istanbul, Turkey
[3] Dicle Univ, Dept Biostat, Fac Med, Diyarbakir, Turkey
[4] Dicle Univ, Dept Physiol, Fac Med, Diyarbakir, Turkey
[5] Dicle Univ, Dept Clin Biochem, Fac Med, Diyarbakir, Turkey
[6] Firat Univ, Dept Clin Biochem, Fac Med, TR-23169 Elazig, Turkey
[7] Istanbul Univ, Dept Internal Med, Div Nephrol, Istanbul Fac Med, Istanbul, Turkey
关键词
chronic kidney disease; leptin; insulin resistance; insulin-like growth factor-1; insulin-like growth factor binding protein-3;
D O I
10.1177/147323000803600317
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study examined the relationship between leptin, insulin-like growth factor-1 (IGF-1), IGF binding protein-3 (IGFBP-3) and insulin resistance in patients with chronic kidney disease (CKD). Levels of leptin, insulin, IGF-1, IGFBP-3 and common routine parameters were measured in 45 patients (23 males and 22 females) with CKD and 45 healthy controls matched for age, gender and body mass index. IGF-1 and IGFBP-3 levels were measured using a two-site immunoradiometric assay. Leptin levels were measured using an enzyme-linked immunosorbent assay. A homeostasis model assessment computer-solved model was used to assess insulin resistance (HOMA-IR). Levels of serum leptin, insulin, IGF-1, IGFBP-3 and HOMA-IR were significantly increased in patients with CKD compared with healthy subjects, whereas fasting blood glucose was not significantly different between the two groups. In patients with CKD, the serum leptin level was significantly correlated with IGF-1, IGFBP-3 and HOMA-IR. In conclusion, this study suggests that there is an interaction between leptin, IGF-1, IGFBP-3 and insulin resistance in patients with CKD.
引用
收藏
页码:522 / 528
页数:7
相关论文
共 50 条
  • [21] Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy
    Ismail, H
    Pollak, M
    Behlouli, H
    Tanguay, S
    Bégin, LR
    Aprikian, AG
    [J]. JOURNAL OF UROLOGY, 2002, 168 (06): : 2426 - 2430
  • [22] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [23] Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II
    Rice, Megan S.
    Tamimi, Rulla M.
    Connolly, James L.
    Collins, Laura C.
    Shen, Dejun
    Pollak, Michael N.
    Rosner, Bernard
    Hankinson, Susan E.
    Tworoger, Shelley S.
    [J]. BREAST CANCER RESEARCH, 2012, 14 (02):
  • [24] The Clinical Values of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Blood and Thyroid Nodules
    Altas, Ayfer
    Kuzu, Fatih
    Arpaci, Dilek
    Unal, Mustafa
    Can, Murat
    Barut, Figen
    Kokturk, Furuzan
    Ilikhan, Sevil Uygun
    Bayraktaroglu, Taner
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [25] Effect of aerobic exercise on insulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in overweight and obese postmenopausal women
    Wieczorek-Baranowska, A.
    Nowak, A.
    Michalak, E.
    Karolkiewicz, J.
    Pospieszna, B.
    Rutkowski, R.
    Laurentowska, M.
    Pilaczynska-Szczesniak, L.
    [J]. JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2011, 51 (03): : 525 - 532
  • [26] Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II
    Megan S Rice
    Rulla M Tamimi
    James L Connolly
    Laura C Collins
    Dejun Shen
    Michael N Pollak
    Bernard Rosner
    Susan E Hankinson
    Shelley S Tworoger
    [J]. Breast Cancer Research, 14
  • [27] Serum insulin-like growth factor-1, insulin-like growth factor binding protein-3, and the pubertal growth spurt in the female rhesus monkey
    Ulijaszek, SJ
    [J]. AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, 2002, 118 (01) : 77 - 85
  • [28] Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis
    Okan, A
    Çömlekçi, A
    Akpmar, H
    Okan, I
    Yesil, S
    Tankurt, E
    Simsek, I
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1212 - 1215
  • [29] Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes
    Chan, SSY
    Twigg, SM
    Firth, SM
    Baxter, RC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6588 - 6595
  • [30] Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction
    Iglesias, P
    Bayón, C
    Méndez, J
    Gancedo, PG
    Grande, C
    Díez, JJ
    [J]. THYROID, 2001, 11 (11) : 1043 - 1048